Human menopausal gonadotropin-induced bioprosthetic valve thrombosis.

ABSTRACT: Bioprosthetic valve thrombosis (BPVT) is a rare but potentially life-threatening complication. Human menopausal gonadotropin (hMG) is commonly used for ovulation induction and has been associated with arterial and venous thrombosis. We reported a case of BPVT related to in vitro fertilization in a 39-year-old female, who underwent redo mitral valve replacement. To the best of our knowledge, this is the first case of hMG-induced BPVT in a young female patient.

SUBMITTER: Abazid RM 

PROVIDER: S-EPMC6057167 | biostudies-literature | 2018 Jul-Sep

REPOSITORIES: biostudies-literature